Startseite>>Signaling Pathways>> Cell Cycle/Checkpoint>> Endomembrane System & Vesicular Trafficking>>(±)-trans-1,2-Bis(2-mercaptoacetamido)cyclohexane

(±)-trans-1,2-Bis(2-mercaptoacetamido)cyclohexane (Synonyms: BMC, Vectrase P)

Katalog-Nr.GC41684

(±)-trans-1,2-Bis(2-mercaptoacetamido)cyclohexane (BMC) is a cyclohexane with two mercaptoacetamido groups.

Products are for research use only. Not for human use. We do not sell to patients.

(±)-trans-1,2-Bis(2-mercaptoacetamido)cyclohexane Chemische Struktur

Cas No.: 257641-01-3

Größe Preis Lagerbestand Menge
10mg
60,00 $
Auf Lager
50mg
271,00 $
Auf Lager
100mg
451,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(±)-trans-1,2-Bis(2-mercaptoacetamido)cyclohexane (BMC) is a cyclohexane with two mercaptoacetamido groups. It is used, both in vitro and in vivo, to promote the correct folding of proteins that require disulfide bonds for functionality. For in vitro applications, BMC may be used to facilitate protein refolding of solubilized proteins from inclusion bodies. Reducing agents, like dithiothreitol, may interfere with refolding. BMC may also be added to the growth medium of cells, including yeast cells, to enhance the folding of proteins with disulfide bonds in vivo.

Bewertungen

Review for (±)-trans-1,2-Bis(2-mercaptoacetamido)cyclohexane

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (±)-trans-1,2-Bis(2-mercaptoacetamido)cyclohexane

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.